This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignees: Korea University Research and Business Foundation, National Institute of Advanced Industrial Science and Technology. Active years: 2016-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 1,274 
1 out of 1,765 
Years Active: 2016-2026
Title: Man Bock Gu: Innovator in Aptamer Screening Methods
Introduction
Man Bock Gu is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of aptamer screening methods, particularly through his innovative approaches that utilize graphene technology. With a total of 3 patents, his work is paving the way for advancements in disease diagnosis.
Latest Patents
His latest patents include a groundbreaking aptamer screening method based on graphene without target immobilization. This method, known as the GO-SELEX method, allows a single-stranded nucleic acid pool to react with non-bound target materials or counter-target materials. After this interaction, the single-stranded nucleic acid that has not bound to either the target or counter-target can be separated using graphene. The specific aptamers obtained through this method hold potential for diagnosing diseases related to the target.
Career Highlights
Man Bock Gu is affiliated with the Korea University Research and Business Foundation, where he continues to advance his research and innovations. His work is characterized by a commitment to enhancing the efficiency and effectiveness of aptamer screening techniques.
Collaborations
He collaborates with notable colleagues, including Tatavarty Rameshwar and Jee Woong Park, contributing to a dynamic research environment that fosters innovation.
Conclusion
Man Bock Gu's contributions to aptamer screening methods exemplify the intersection of technology and healthcare. His innovative approaches are set to make a lasting impact on disease diagnosis and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile